Glycine Transporters and Receptors as Targets for Analgesics
The suitability of modulating glycinergic neurotransmission for the treatment of inflammatory and chronic pain has gained widespread recognition, with glycine receptors (GlyRs) and glycine transporters (GlyT1 and GlyT2) now considered key therapeutic targets [...]
Guardado en:
Autores principales: | Robert J. Harvey, Robert J. Vandenberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4ad0677329414b719d69241e3f96cf27 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunotoxins: From Design to Clinical Application
por: Robert J. Kreitman, et al.
Publicado: (2021) -
New Evidence of Renal and Cardiovascular Alterations Promoted by Bisphenol A
por: Rafael Moreno-Gómez-Toledano, et al.
Publicado: (2021) -
Treating Cancers Using Nature’s Medicine: Significance and Challenges
por: Samson Mathews Samuel, et al.
Publicado: (2021) -
Reimagining the Power of Nucleic Acids as Therapeutic and Diagnostic Agents
por: Anthony Berdis
Publicado: (2021) -
Evolutionary and Molecular Aspects of Plastid Endosymbioses
por: Miroslav Oborník, et al.
Publicado: (2021)